Dose comparisons of clopidogrel and aspirin in acute coronary syndromes

CURRENT-OASIS 7 Investigators; Shamir R Mehta; Jean-Pierre Bassand; Susan Chrolavicius; Rafael Diaz; John W Eikelboom; Keith A A Fox; Christopher B Granger; Sanjit Jolly; Campbell D Joyner; Hans-Jurgen Rupprecht; Petr Widimsky; Rizwan Afzal; Janice Pogue; Salim Yusuf

doi:10.1056/NEJMoa0909475

Dose comparisons of clopidogrel and aspirin in acute coronary syndromes

CURRENT-OASIS 7 Investigators, Shamir R Mehta, Jean-Pierre Bassand, Susan Chrolavicius, Rafael Diaz, John W Eikelboom, Keith A A Fox, Christopher B Granger, Sanjit Jolly, Campbell D Joyner, Hans-Jurgen Rupprecht, Petr Widimsky, Rizwan Afzal, Janice Pogue, Salim Yusuf

Research output: Contribution to journal › Article › peer-review

Abstract / Description of output

Clopidogrel and aspirin are widely used for patients with acute coronary syndromes and those undergoing percutaneous coronary intervention (PCI). However, evidence-based guidelines for dosing have not been established for either agent.

Original language	English
Pages (from-to)	930-942
Number of pages	13
Journal	New England Journal of Medicine
Volume	363
Issue number	10
DOIs	https://doi.org/10.1056/NEJMoa0909475
Publication status	Published - 2010

Access to Document

10.1056/NEJMoa0909475

Cite this

CURRENT-OASIS 7 Investigators, Mehta, S. R., Bassand, J.-P., Chrolavicius, S., Diaz, R., Eikelboom, J. W., Fox, K. A. A., Granger, C. B., Jolly, S., Joyner, C. D., Rupprecht, H.-J., Widimsky, P., Afzal, R., Pogue, J., & Yusuf, S. (2010). Dose comparisons of clopidogrel and aspirin in acute coronary syndromes. New England Journal of Medicine, 363(10), 930-942. https://doi.org/10.1056/NEJMoa0909475

@article{436830f356ea43a8a19ddfbb53e76057,

title = "Dose comparisons of clopidogrel and aspirin in acute coronary syndromes",

abstract = "Clopidogrel and aspirin are widely used for patients with acute coronary syndromes and those undergoing percutaneous coronary intervention (PCI). However, evidence-based guidelines for dosing have not been established for either agent.",

author = "{CURRENT-OASIS 7 Investigators} and Mehta, {Shamir R} and Jean-Pierre Bassand and Susan Chrolavicius and Rafael Diaz and Eikelboom, {John W} and Fox, {Keith A A} and Granger, {Christopher B} and Sanjit Jolly and Joyner, {Campbell D} and Hans-Jurgen Rupprecht and Petr Widimsky and Rizwan Afzal and Janice Pogue and Salim Yusuf",

year = "2010",

doi = "10.1056/NEJMoa0909475",

language = "English",

volume = "363",

pages = "930--942",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "MASSACHUSETTS MEDICAL SOC",

number = "10",

}

CURRENT-OASIS 7 Investigators, Mehta, SR, Bassand, J-P, Chrolavicius, S, Diaz, R, Eikelboom, JW, Fox, KAA, Granger, CB, Jolly, S, Joyner, CD, Rupprecht, H-J, Widimsky, P, Afzal, R, Pogue, J & Yusuf, S 2010, 'Dose comparisons of clopidogrel and aspirin in acute coronary syndromes', New England Journal of Medicine, vol. 363, no. 10, pp. 930-942. https://doi.org/10.1056/NEJMoa0909475

TY - JOUR

T1 - Dose comparisons of clopidogrel and aspirin in acute coronary syndromes

AU - CURRENT-OASIS 7 Investigators

AU - Mehta, Shamir R

AU - Bassand, Jean-Pierre

AU - Chrolavicius, Susan

AU - Diaz, Rafael

AU - Eikelboom, John W

AU - Fox, Keith A A

AU - Granger, Christopher B

AU - Jolly, Sanjit

AU - Joyner, Campbell D

AU - Rupprecht, Hans-Jurgen

AU - Widimsky, Petr

AU - Afzal, Rizwan

AU - Pogue, Janice

AU - Yusuf, Salim

PY - 2010

Y1 - 2010

N2 - Clopidogrel and aspirin are widely used for patients with acute coronary syndromes and those undergoing percutaneous coronary intervention (PCI). However, evidence-based guidelines for dosing have not been established for either agent.

AB - Clopidogrel and aspirin are widely used for patients with acute coronary syndromes and those undergoing percutaneous coronary intervention (PCI). However, evidence-based guidelines for dosing have not been established for either agent.

UR - http://www.scopus.com/inward/record.url?scp=77956290748&partnerID=8YFLogxK

U2 - 10.1056/NEJMoa0909475

DO - 10.1056/NEJMoa0909475

M3 - Article

C2 - 20818903

SN - 0028-4793

VL - 363

SP - 930

EP - 942

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 10

ER -

Dose comparisons of clopidogrel and aspirin in acute coronary syndromes

Abstract / Description of output

Access to Document

Other files and links

Fingerprint

Cite this